<?xml version="1.0" encoding="UTF-8"?>
<ref id="B328-vaccines-08-00036">
 <label>328.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Douam</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Albrecht</surname>
    <given-names>Y.E.S.</given-names>
   </name>
   <name>
    <surname>Hrebikova</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sadimin</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Davidson</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kotenko</surname>
    <given-names>S.V.</given-names>
   </name>
   <name>
    <surname>Ploss</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo</article-title>
  <source>Mbio</source>
  <year>2017</year>
  <volume>8</volume>
  <pub-id pub-id-type="doi">10.1128/mBio.00819-17</pub-id>
  <?supplied-pmid 28811340?>
  <pub-id pub-id-type="pmid">28811340</pub-id>
 </element-citation>
</ref>
